HHS Passes Clinical Trial Reporting Authority To FDA

Law360, New York (September 26, 2012, 6:40 PM EDT) -- The U.S. Department of Health and Human Services is delegating some authority over clinical trial reporting and monitoring to the U.S. Food and Drug Administration, according to a notice published Wednesday in the Federal Register.

The clinical trial registry and results data bank, which exists as ClinicalTrials.gov, was created and maintained solely by HHS, as required under the Public Health Service Act. Now, Secretary Kathleen Sebelius has passed on some of the responsibility overseeing information on the site to FDA Commissioner Margaret Hamburg.

The action gives...
To view the full article, register now.